Neglected geriatric assessment and overtreatment of older patients with pancreatic cancer - Results from a prospective phase IV clinical trial
Authors:
- 3 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Geriatric Oncology
- Vol. 13 (5) , 662-666
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Forschungsgemeinschaft (EB 187/8–1)
- Hector Stiftung
- Celgene
This publication has 16 references indexed in Scilit:
- Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 StudyJournal of Clinical Oncology, 2016
- Management of pancreatic cancer in the elderlyWorld Journal of Gastroenterology, 2016
- Performance of Two Geriatric Screening Tools in Older Patients With CancerJournal of Clinical Oncology, 2014
- Functional Decline in Older Patients With Cancer Receiving First-Line ChemotherapyJournal of Clinical Oncology, 2013
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus GemcitabineNew England Journal of Medicine, 2013
- Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric studyAnnals of Oncology, 2013
- Biological, Clinical, and Psychosocial Correlates at the Interface of Cancer and Aging ResearchJNCI: Journal of the National Cancer Institute, 2012
- EORTC elderly task force position paper: Approach to the older cancer patientEuropean Journal of Cancer, 2010
- Management of Cancer in the Older Person: A Practical ApproachThe Oncologist, 2000
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997